Regulating Weight-Loss Drugs and Supplements
Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements.
Off-Label Drug Use Liability
Scholar argues that FDA approval should not save drug makers from state-law claims arising from off-label use.
Global Perspectives on Psychedelics Regulation
Experts discuss the benefits and drawbacks of existing regulatory frameworks for psychedelics.
Emergency Use or Overuse?
Experts discuss FDA’s COVID-19 emergency authorizations and how to recalibrate the regulatory mechanism.